cp wire

CP Wire Articles

European Commission Approves Janssen's Erleada for Patients at High Risk of Developing Metastatic Prostate Cancer
  • Erleada is also approved in the US for the treatment of non-metastatic castration-resistant prostate cancer


The Janssen Pharmaceutical Companies of Johnson & Johnson... read more

Wed, 01/16/19 - 09:52 am
Krystal Biotech Ramps Up to Manufacture Gene Therapy to Treat Dystrophic Epidermolysis Bullosa
  • Facility will officially open in 1Q 2019
  • Ph I/II study on KB103 interim results met primary and secondary endpoints


Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS... read more

Tue, 01/15/19 - 09:51 am
FDA Accepts Pfizer Submissions for Review of Treatment for Rare Amyloid Related Heart Disease
  • The tafamidis meglumine form (20 mg capsule) has been granted Priority Review

  • Tafamidis was granted Orphan Drug Designation for ATTR-CM in both the EU and US in 2012

... read more

Mon, 01/14/19 - 10:09 am
Release: Vascular Therapies Appoints John McDermott as Chief Executive Officer
Cresskill, NJ.  Vascular Therapies, a biotechnology company focused on improving outcomes for patients with advanced kidney disease today announced the appointment of John... read more
Thu, 01/10/19 - 03:22 pm
Lundbeck Partners with AI Driven Numerate to Tackle Central Nervous System Disorders

Numerate, Inc. announced on 1/7/19 a multi-target research collaboration with Lundbeck Pharmaceutical to identify clinical candidates for the treatment of disorders in the central nervous system,... read more

Mon, 01/7/19 - 10:05 am

Pages